Generic Timolol Maleate Ophthalmic Gel-Forming Solution from Japan
Gel-forming ophthalmic solution with timolol maleate for once-daily glaucoma treatment, in retail multi-dose bottles. It qualifies for HTS 3004.90.92.72 as an eye-affecting medicament in measured doses containing timolol maleate, distinct from standard drops. The gel matrix provides prolonged release for therapeutic efficacy.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Ensure gel formulation stability testing reports are available for CBP review during ophthalmic import clearance
• Comply with USP standards for sterility and include batch certificates to expedite FDA admission
• Watch for misclassification pitfalls by specifying 'measured dose retail packing' in entry documentation